Combined Ranibizumab And Stereotactic X-Ray Therapy Shows Promise In Polypoidal Choroidal Vasculopathy

Friday, October 4, 2013

Comments

Ocular Surgery News

Preliminary data of a pilot study on combined ranibizumab and stereotactic X-ray therapy for polypoidal choroidal vasculopathy showed encouraging anatomical and visual acuity outcomes, according to a speaker here.

Full Story

Causes of aqueous tear deficiency include all of the following except:
1. Riley-Day Syndrome
2. Anhidrotic Ectodermal Dysplasia
3. Shy-Drager Syndrome
4. Fraser Syndrome
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Combined Ranibizumab And Stereotactic X-Ray Therapy Shows Promise In Polypoidal Choroidal Vasculopathy

Comments

Quick Quiz

Causes of aqueous tear deficiency include all of the following except:

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

3nethra classic Ophthalmic Imaging Device

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us